Australia markets open in 6 minutes

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.27-0.13 (-1.14%)
At close: 04:00PM EDT
11.27 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 706.69M
Enterprise value 653.79M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.71
Price/book (mrq)5.12
Enterprise value/revenue 3.49
Enterprise value/EBITDA -16.76

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-56.62%
S&P500 52-week change 321.61%
52-week high 327.70
52-week low 35.27
50-day moving average 313.19
200-day moving average 313.80

Share statistics

Avg vol (3-month) 3415.88k
Avg vol (10-day) 3299.62k
Shares outstanding 561.94M
Implied shares outstanding 661.94M
Float 844.28M
% held by insiders 125.91%
% held by institutions 167.55%
Shares short (28 Mar 2024) 42.64M
Short ratio (28 Mar 2024) 46.13
Short % of float (28 Mar 2024) 45.47%
Short % of shares outstanding (28 Mar 2024) 44.27%
Shares short (prior month 29 Feb 2024) 43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -26.47%
Operating margin (ttm)-10.78%

Management effectiveness

Return on assets (ttm)-15.59%
Return on equity (ttm)-49.91%

Income statement

Revenue (ttm)187.12M
Revenue per share (ttm)3.08
Quarterly revenue growth (yoy)25.00%
Gross profit (ttm)N/A
EBITDA -46.39M
Net income avi to common (ttm)-49.53M
Diluted EPS (ttm)-0.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.2M
Total cash per share (mrq)2
Total debt (mrq)70.3M
Total debt/equity (mrq)50.97%
Current ratio (mrq)4.41
Book value per share (mrq)2.23

Cash flow statement

Operating cash flow (ttm)-34.58M
Levered free cash flow (ttm)-33.02M